発育性および性脳症の治療にシナプス細胞外ミオイノシトールの使用
E Naomi Vos1,2,3,4,5, Didem Demirbas6,7,8, Lance Rodan6
1Department of Pediatrics, MosaKids Children's Hospital, Maastricht University Medical Centre, Maastricht, Netherlands.
Annals of the Child Neurology Society
|August 29, 2025
まとめ
PLCB1に関連したDEEの患者で,腸内ミオイノシトール補給は,発作と脳縮を安全に改善しました. この治療はマウスモデルでも死亡を予防し,胎児の生前におけるミオイノシトールの新たな役割を示唆した.
科学分野:
- 神経科学
- 生物化学
- 遺伝学
背景:
- 発育性および性脳症 (DEE) は,高い死亡率を持つ重度の神経疾患である.
- 標準的な抗発作薬は DEE に対してしばしば無効です.
- PLCB1遺伝子の欠損は,DEEの既知の原因である.
研究 の 目的:
- PLCB1に関連するDEEの追加療法としての腸内ミオイノシトール補給の有効性と安全性を調査する.
- 産前におけるミオ・イノシトールの役割を,マウスモデルで調べる.
主な方法:
- ミオイノシトールの濃度は,血,尿,脊髄液でGC/ MSを用いて測定された.
- 脳機能と構造はMRIとEEGを用いて評価された.
- 安全性試験はFDAのガイドラインに従って行われました.
- ミオイノシトールは,妊娠中のSlc5a3 キャリアマウスに投与された.
主要な成果:
- 腸内ミオイノシトールのサプリメントは患者でよく耐えました.
- 発作が減り 脳縮が安定しました
- 妊娠中のマウスにミオイノシトールを投与すると,ノックアウトした子でミオイノシトールのレベルが上昇し,死亡率が防止されました.
結論:
- 高用量の腸内ミオイノシトールは,重度の性脳症に対する安全で潜在的に効果的な治療法である.
- ミオイノシトールは胎児の脳の発達に 重要な役割を果たす可能性があります
- 重度の性脳症の乳児に対するミオ・イノシトールのさらなる臨床試験が必要である.
さらに関連する動画
関連する概念動画
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
635
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
635
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
445
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
445
01:14Antiepileptic Drugs: Glutamate Antagonists
511
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
511
01:20Antiepileptic Drugs: Potassium Channel Activators
274
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
274
01:24Epilepsy and Seizures: Overview
275
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
275
01:08Antiepileptic Drugs: Sodium Channel Blockers
869
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
869